Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-02-24 @ 2:29 PM
Study NCT ID:
NCT02522767
Status:
COMPLETED
Last Update Posted:
2021-03-15
First Post:
2015-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Sponsor:
Ferring Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-12
First Submit QC Date:
None
Study First Post Date:
2015-08-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-01-08
Results First Submit QC Date:
None
Results First Post Date:
2021-03-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-01-30
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-02-19
Last Update Post Date:
2021-03-15
Last Update Post Date Type:
ACTUAL